Skip to main content
. 2023 Jan 11;158(3):264–271. doi: 10.1001/jamasurg.2022.6998

Table 1. Baseline Patient Characteristics.

Characteristic Patients, No. (%) SMD
Surgical group (n = 303 709) Control group (n = 605 140)
Sex
Female 245 819 (80.9) 500 929 (82.8) 0.048
Male 57 890 (19.1) 104 211 (17.2)
Age, mean (SD), y 40.2 (11.9) 40.4 (12.5) 0.016
Age, y
18-29 66 175 (21.8) 138 336 (22.9) 0.089
30-39 82 835 (27.3) 170 763 (28.2)
40-49 81 660 (26.9) 142 604 (23.6)
50-59 55 058 (18.1) 110 140 (18.2)
≥60 17 981 (5.9) 43 297 (7.1)
BMI
30-40: Moderate to severe obesity 126 228 (41.6) 404 796 (66.9) 0.527
>40-50: Morbid obesity 152 557 (50.2) 175 201 (29.0)
>50: Extreme obesity 24 924 (8.2) 25 143 (4.2)
CCI, mean (SD) 0.52 (1.39) 0.45 (1.37) 0.047
CCI
0 233 064 (76.7) 485 970 (80.3) 0.093
1-2 56 626 (18.6) 92 051 (15.2)
3-4 9996 (3.3) 18 777 (3.1)
>4 4023 (1.3) 8342 (1.4)
Bariatric procedure
Adjustable gastric banding 39 453 (13.0) NA NA
Biliopancreatic diversion 1157 (0.4) NA
Gastric bypass 84 187 (27.7) NA
Sleeve gastrectomy 178 912 (58.9) NA

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CCI, Charlson Comorbidity Index; NA, not applicable; SMD, standardized mean difference.